Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

Nivolumab combined with brentuximab vedotin with or without mediastinal radiotherapy for relapsed/refractory primary mediastinal large B-cell lymphoma

Gustave Roussy, Université Paris-Saclay, Département d’Hématologie, 94800 Villejuif
AP-HP, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI ; Université de Paris, F-75010 Paris
Gustave Roussy, Université Paris-Saclay, Service de Biostatistique et d’Epidémiologie, et Inserm, CESP U1018, Oncostat, 94800 Villejuif
Centre Hospitaliser d’Argenteuil, service d’hématologie, Argenteuil
Centre Hospitalier Annecy-Genevois, service d’hématologie, Epagny-Metz-Tessy
AP-HP, Hôpital Saint-Louis, service de Cancérologie-Radiothérapie, Paris, France; INSERM U1160, Université Paris Cité, Paris
Centre Henri Becquerel, Département d’Hématologie et INSERM U1245, Rouen
AP-HP, Hôpital Saint-Louis, Hemato-oncologie, DMU DHI ; Université de Paris, F-75010 Paris
Haematologica Early view May 2, 2024 https://doi.org/10.3324/haematol.2023.284689

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2023.284689
Pubmed
38695142
 
Published
2024-05-02
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2024 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
418
PDF Downloads
167

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2024 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online